FDA Would Like European Union To Adopt DTC Ads To Improve Public Health
This article was originally published in The Pink Sheet Daily
Executive Summary
Rx advertising prompts patients to check with a doctor for treatment, FDA Deputy Commissioner Crawford says. Agency may approach manufacturers directly on how to present information to consumers.
You may also be interested in...
FDA Releases DTC Guidances; "Not The Last Word" On Ads, Commissioner McClellan Says
The agency pledges further review of its guidance on direct-to-consumer advertising. Broadcast ads for drugs and enforcement actions against repeat offenders could see more attention.
U.S. Patents Could Limit President's AIDS Drug Assistance Plan, GAO Says
The U.S. Global AIDS Coordinator's Office suggests it will use its authority to purchase an FDA-approved generic antiretroviral product for which permission could not be obtained from the patent holder. FDA grants tentative approval to a South African firm for a generic co-packaged version of Combivir and Viramune.
Sanofi-Aventis' Once-Daily Allegra-D To Launch Mid-Year
With the exception of Allegra, the company's "top 15" products produced double-digit sales growth in 2004. The fastest growing products include the long-acting insulin Lantus (up 80%), the osteoporosis agent Actonel (up 60%) and the oncologic Eloxatin (up 57%).